Metaxalone Tablets

SOL #: SPE2D2-26-R-0001 Solicitation

Overview

Buyer

PHILADELPHIA, PA, 19111, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Nov 7, 2025
2
Last Updated
Dec 22, 2025
3
Submission Deadline
Jan 5, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Solicitation Attached

Amendment 0003 added

People

Points of Contact

Jeremy BrownPRIMARY
Jason WraySECONDARY

Files

Files

Download
Download
Download
Download

Versions

Version 5Viewing
Solicitation
Posted: Dec 22, 2025
Version 4
Solicitation
Posted: Dec 8, 2025
View
Version 3
Solicitation
Posted: Nov 12, 2025
View
Version 2
Solicitation
Posted: Nov 12, 2025
View
Version 1
Solicitation
Posted: Nov 7, 2025
View
Metaxalone Tablets | GovScope